Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma.
The effects of inhaling 200 mu g of salbutamol were compared with those of inhaling 40 mu g of ipratropium bromide singly and in combination with salbutamol in eight patients with bronchitis and eight asthmatic patients in a double-blind controlled trial. Changes in airways resistance were assessed by measuring the forced expiratory volume in 1 second and specific airways conductance. Both drugs were significantly better in relieving airways obstruction than placebo. Salbutamol was significantly more effective than ipratropium bromide in patients with asthma, but in the patients with bronchitis there was no significant difference between salbutamol and ipratropium bromide. The combination of the two drugs produced a slightly greater and longer response than either drug alone but this was not significant.
D000336:Aerosols; D000402:Airway Obstruction / Q000188:drug therapy; D000403:Airway Resistance; D000420:Albuterol / Q000008:administration & dosage / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001285:Atropine / Q000627:therapeutic use; D001286:Atropine Derivatives; D001991:Bronchitis / Q000188:drug therapy*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D010276:Parasympatholytics / Q000008:administration & dosage / Q000627:therapeutic use*; D011407:Propane / Q000031:analogs & derivatives / Q000627:therapeutic use; D012138:Respiratory Therapy; D012907:Smoking; D013147:Spirometry
D000336:Aerosols; D001286:Atropine Derivatives; D010276:Parasympatholytics; D001285:Atropine; D000420:Albuterol; D011407:Propane